Omar M. Ghanem, M.D.

Closed for Enrollment

• Hybrid Argon Plasma Coagulation and Endoscopic Sleeve Gastroplasty Trial (HAPCET): A Single-center Randomized Controlled Trial (HAPCET) Rochester, Minn.

  The objectives of this study are to assess the safety and durability of combined hybrid APC and ESG compared to traditional ESG, and to assess weight loss and improvement in obesity-related co-morbidities in combined hybrid APC and ESG compared to ESG alone.

   

   

   

• MULTICENTER SINGLE-BLIND RANDOMIZED CONTROLLED TRIAL OF LAPAROSCOPIC PARAESOPHAGEAL HIATAL HERNIA REPAIR COMBINED WITH TRANSORAL INCISIONLESS FUNDOPLICATION VERSUS LAPAROSCOPIC NISSEN FUNDOPLICATION FOR TREATMENT OF GASTROESOPHAGEAL REFLUX DISEASE IN PATIENTS REQUIRING HIATAL HERNIA REPAIR (TIF vs LNF) Rochester, Minn.

  The purpose of this study is to compare treatment effectiveness and safety between Transoral Incisionless Fundoplication (TIF) and Laparoscopic Nissen Fundoplication (LNF) in GERD patients with hiatal hernia undergoing hernia repair.

• Prediction of Post-laparoscopic Sleeve Gastrectomy Gastroesophageal Reflux Disease with an Endolumenal Functional Lumen Imaging Probe (EndoFLIP) Rochester, Minn.

  The purpose of this study is to identify a predictive model for worsening of preexisting gastroesophageal reflux disease (GERD) or development of de novo GERD after laparoscopic sleeve gastrectomy (LSG) by using EndoFLIP, upper endoscopy and esophageal manometry to assess patients preoperatively in a discovery cohort.  This prospective predictive model will then identify sensitivity, specificity, positive and negative predictive values for prediction of worsening or de novo GERD.